Partner With Us NRI

Details you don’t want to miss

Issue size

Upto Rs. 700 cr

Issue Period

Dec 16 – Dec 20, 2021

Price band

Rs. 265 to Rs. 274

Market lot / Multiples


Issue Timeline

Bidding period

Dec 16 - Dec 20, 2021


Dec 23, 2021

Refund Initiation

Dec 24, 2021

Share Crediting

Dec 27, 2021


Dec 28, 2021

Supriya Lifescience Ltd Company Overview

One of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of March 31, 2021, they have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti allergic.

Were among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume (Source: CRISIL Report as per Company DRHP).

Read More

30 second IPO overview

Ask Our Analyst

Please enter valid captcha

Expert Review Video

Strengths & Risks associated

Top 0 Strengths

  • 1

    Significant scale with leadership position across key & niche products

    The company believes their core strength lies in identifying generic molecules (off-patent) in the existing therapeutic segments which fits in to existing chemistry and production infrastructure and their ability to develop the product and scale-up production.

  • 2

    Backward integrated business model

    As on May 2021, 11 of the existing products were backward integrated, which contributed 63.25% of the total revenue for nine months period ended December 31, 2020.

  • 3

    Geographically diversified revenues with a global presence across 78 countries

    Customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc and AT Planejamento E Desenbolvimento De Negocios Ltda etc.

Top 0 risks

  • 1

    The business is subject to extensive regulation

    Failure to comply with regulations prescribed by governments and regulatory agencies or to obtain, maintain or renew statutory and regulatory licenses, permits and approvals required to operate business, results of operations and financial condition could be adversely affected.

  • 2

    Manufacturing or quality control problems in such an industry may be detrimental

    Such events may damage the company's reputation and expose them to litigation or other liabilities, which could adversely affect the results of operations and financial condition.


  • Net Worth
  • Revenue from Operations
  • Total Borrowings
  • Restated Profit for the Year
  • Restated Earnings per Share

Net Worth

Revenue from Operations

Total Borrowings

Restated Profit for the Year

Restated Earnings per Share

Industry Trends

Past performance of IPOs

Why invest in IPO through ICICIdirect

Paperless Applications

Hassle-free refunds

Convenient investments within a few clicks

Multiple modes of application


An Initial Public Offering (IPO) is when a company issues common stock or shares to the public for the first time. It is the process where a privately held company becomes a publicly traded company with the initial sale of its stock. An IPO is a tool that companies use to secure capital through investments for future use. In most instances, this investment is used to expand or improve the business.

A price band is a price floor and a cap between which a seller will let buyers place bids on a security, usually during an initial public offering (IPO).

Minimum Order Quantity, as name says, is the minimum number of shares investors can apply while bidding in an IPO. If investors want to bid for more shares, they can apply in multiples of IPO market lot (lot Size or IPO bid lot) of shares.

If an investor wants to place bids for less than Rs.2 lacs, he needs to apply in the Retail segment. If an investor wants to bid for more than Rs.2 lacs, he needs to apply in the HNI segment.

Cut-off price is the offer price, finalized by a company in consultation with the book running lead managers (BRLMs), which could be any price within the price band. Applying on Cut-off price means the investor is ready to pay whatever price is decided by the company at the end of the book-building process.

When applying at a cut-off price, an investor has to pay the highest price while placing the bid. If a company decides the final price lower than the highest price asked for IPO, the remaining amount is returned to the retail investor.

An investor can apply in all Mainboard IPOs through ICICIdirect. However, if the investor wants to apply in SME IPOs, he/she can do it through the net banking portal of ICICI Bank.

ASBA stands for "Applications Supported by Blocked Accounts". At the time of bidding, investors’ account is blocked to the extent of the bid amount and debited only at the time of allotment. This facility is being offered by ICICIDirect in affiliation with ICICI Bank Limited.

In other payment options, the bid amount is debited when investors’ bid application is placed with the stock exchanges. Under the ASBA process, the amount will be debited from investors’ bank account to the extent of successful allotment at the time of allotment. Until such allotment, the amount will remain blocked in investors’ bank account.

Application under this facility can be placed only for Book Built Public Issues.

An investor can place maximum of 3 bids in an issue.

The investor with Demat account in ICICIdirect can apply in an IPO by logging in to his ICICIdirect Account. The investor needs to select IPO and then the name of the IPO in which he would like to apply. Given below is the path:

Login to ICICIdirect account >> IPO >> Name of IPO

Investor can apply in the retail section of an IPO through iDirect Portal even if he has a 2-in-1 account (Demat, Trading Accounts) with us and Bank account with third party.

Yes, the investor can revise or withdraw the bids after application. It can be done only once the order is executed. The investor needs to go to the IPO Order Book and select the Transaction Id and then click on Withdraw Application/ Revise Bid. The application in the non- institutional category cannot be withdrawn but can only be revised.

However, this needs to be done during the issue itself and cannot be done after the issue is closed. In case of ASBA applications, for upward revision of bid, additional lien will be marked to the extent of incremental amount. However, in case of downward revision, differential money blocked earlier will not be released. Such amount, if any, will be released after allotment

No, one person cannot apply multiple times with same Demat/PAN for an IPO. If an investor applies in an IPO though multiple applications with same Demat account or same PAN Number, his applications will be rejected.

If an investor would like to place order for multiple applications, he/she can apply with his/her family member's name. But, all eligible family members should have a Demat account and a PAN number.

In cases where issue is over-subscribed, bidding for more than 1 lot from the same account doesn’t help as maximum of only 1 lot can be provided against each application. However, if the investor applies for 1 lot from different accounts, the probability of allocation of shares increases.